Control of arterial hemorrhage using percutaneous arterial catheter techniques in patients with gynecologic malignancies

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.

British journal of cancer·2014

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

British journal of cancer·2013

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

British journal of cancer·2013

Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays.

Oncogene·2012

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.

British journal of cancer·2012

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.

Oncogene·2011

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Gynecologic oncology·2026

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Gynecologic oncology·2026

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Gynecologic oncology·2026

Immunotherapy-induced thyroid dysfunction and diabetes mellitus in gynecologic oncology patients: a retrospective cohort study.

Gynecologic oncology·2026

The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women.

Gynecologic oncology·2026

Survival associated with recommended risk-reducing interventions for individuals with pathogenic variants in BRCA1/2.

Gynecologic oncology·2026

Association Between Blood Transfusion Volume and Adverse Clinical Outcomes in Chronic Liver Disease: A Retrospective Observational Study.

Cureus·2026

Hematoma expansion in intracerebral hemorrhage: neuroimaging biomarkers, radiomics-based prediction models, and clinical translation.

Frontiers in human neuroscience·2026

Neuroprotection with Hemoglobin-based Oxygen Carriers in Ischemic Stroke: A Narrative Review of Preclinical Studies.

JMA journal·2026

ISG Task Force on Upper Gastrointestinal Bleeding (UGIB)-Comparison of Risk Scores in Nonvariceal Bleeding-A Prospective Multicenter Study.

JGH open : an open access journal of gastroenterology and hepatology·2026

Lymphocyte-to-monocyte ratio predicts survival in localized osteosarcoma in Vietnamese patients.

iScience·2026

Association of a platelet function testing-guided intensified antiplatelet strategy with thromboembolic events after EP2 stent-assisted coil embolization in patients with unruptured intracranial aneurysms.

Frontiers in neurology·2026

Related Experiment Videos

Control of arterial hemorrhage using percutaneous arterial catheter techniques in patients with gynecologic

Related Concept Videos

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays.

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Immunotherapy-induced thyroid dysfunction and diabetes mellitus in gynecologic oncology patients: a retrospective cohort study.

The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women.

Survival associated with recommended risk-reducing interventions for individuals with pathogenic variants in BRCA1/2.

Association Between Blood Transfusion Volume and Adverse Clinical Outcomes in Chronic Liver Disease: A Retrospective Observational Study.

Hematoma expansion in intracerebral hemorrhage: neuroimaging biomarkers, radiomics-based prediction models, and clinical translation.

Neuroprotection with Hemoglobin-based Oxygen Carriers in Ischemic Stroke: A Narrative Review of Preclinical Studies.

ISG Task Force on Upper Gastrointestinal Bleeding (UGIB)-Comparison of Risk Scores in Nonvariceal Bleeding-A Prospective Multicenter Study.

Lymphocyte-to-monocyte ratio predicts survival in localized osteosarcoma in Vietnamese patients.

Association of a platelet function testing-guided intensified antiplatelet strategy with thromboembolic events after EP2 stent-assisted coil embolization in patients with unruptured intracranial aneurysms.

Related Experiment Videos

Control of arterial hemorrhage using percutaneous arterial catheter techniques in patients with gynecologic...

Related Concept Videos

Related Articles

Control of arterial hemorrhage using percutaneous arterial catheter techniques in patients with gynecologic